What did Promisia Healthcare Limited announce?
Promisia Healthcare Limited (NZX: PHL) filed “Annual Shareholders Meeting 2026” with NZX on 13 August 2026, as an agm announcement.
From the announcement:“Dear Shareholder Please find enclosed notice of Promisia Healthcare Limited’s Annual Shareholders’ Meeting which will be held at Duncan Cotterill, 148 Victoria Street, Christchurch on Thursday, 27 August 2026 starting at 3pm.”
- Which company?
- Promisia Healthcare Limited (NZX: PHL)
- When was it filed?
- 13 August 2026
- Where is the original?
- NZX announcement
Annual Shareholders Meeting 2026
Dear Shareholder
Please find enclosed notice of Promisia Healthcare Limited’s Annual Shareholders’ Meeting which
will be held at Duncan Cotterill, 148 Victoria Street, Christchurch on Thursday, 27 August 2026
starting at 3pm. If you cannot attend in person, the meeting will be streamed and can be viewed at
this link: Microsoft Teams Meeting.
In addition to usual annual meeting business and a request for shareholders to consider approving
an increase to the Director fee pool, shareholders will be invited to discuss and then vote on a
proposed acquisition by Promisia.
Background
As announced to the market on 6 August 2026, Promisia has entered a conditional agreement to
acquire the Chatswood Retirement Village (Chatswood) for a purchase price of $25 million (the
Acquisition).
Chatswood is in Opawa, Christchurch and located in close proximity to Promisia’s existing care
facility in East Christchurch, Aldwins House. Together, they provide Promisia two of East
Christchurch’s largest care facilities and create a broader integrated offering across rest home,
hospital-level care, care suites, serviced apartments and ORA-based retirement living.
Chatswood comprises an integrated care facility and retirement village with 100 operational beds
and units, including 29 care beds, 42 care suites and 29 serviced apartments. Occupancy across
those operational beds and units as at 30 June 2026 was c.95%.
The Acquisition is a significant growth initiative for Promisia and is consistent with its stated strategy
of building regional scale through strategically located acquisitions, strengthening local recognition
and offering residents a broader range of high-quality care and accommodation options.
Acquisition terms
The purchase price for the Acquisition is $25 million, comprised of:
• $24 million cash payable on completion;
• An issue of up to 1 million fully paid ordinary shares in Promisia at an issue price of $0.50 per
share (Consideration Shares); and
• An issue of 1 million convertible notes, each with a face value of $0.50 per note, convertible
into fully paid ordinary shares in Promisia (Convertible Notes).
The cash component of the purchase price will be funded through cash on hand and debt financing.
The Acquisition is scheduled to settle on 1 October 2026. Further information on the transaction
structure can be found in the explanatory notes in the enclosed notice of meeting.
Please note that while the issue price per share is at a discount to the prevailing market price, it
reflects the agreed per share price when negotiations to acquire Chatswood commenced.
Promisia will debt fund the Acquisition with a new funding line from Bank of New Zealand. Promisia
has received committed terms from Bank of New Zealand for this funding and has satisfied all
conditions precedent to that funding that it can satisfy at this time. No capital raising is proposed to
finance the Acquisition.
2
Board recommendation
The Board (excluding Rhonda Sherriff, who is interested in the Acquisition) considers that the
Acquisition and all related transactions are in the best interests of Promisia and its shareholders and
recommends that shareholders vote in favour of the resolutions outlined in the notice of meeting.
The Board encourages you to read this notice of meeting and to exercise your right to vote.
The enclosed notice of meeting and Proxy Form contain detailed instructions on how shareholders
may lodge their vote or appoint a proxy to vote on their behalf if they are unable to attend the
meeting.
We look forward to seeing you at the meeting.
Issued by the Promisia non-interested Directors:
Tom Brankin Tony Mortenson
Director Director
Craig Percy Jill Hatchwell
Independent Director Independent Director
3
NOTICE OF ANNUAL MEETING
Notice is hereby given that the annual meeting of shareholders of Promisia Healthcare Limited
(Promisia) (Meeting) will be held at Duncan Cotterill, 148 Victoria Street, Christchurch on Thursday
27 August 2026, starting at 3pm.
Agenda
A. Chair’s introduction
B. Presentation to shareholders
C. Questions
D. Resolutions
Business
Resolutions
To consider and, if thought fit, to pass the following ordinary resolutions:
1. Auditor’s remuneration: To authorise the directors to fix the auditor’s remuneration for the
ensuing year.
2. Re-election of Craig Percy: That Craig Percy, who retires by rotation and is eligible for re-
election, be re-elected as a director of Promisia.
3. Re-election of Rhonda Sherriff: That Rhonda Sherriff, who retires by rotation and is eligible
for re-election, be re-elected as a director of Promisia.
4. Approval of Acquisition: That Promisia undertaking the Acquisition under Listing Rule 5.1.1
(major transaction), 5.2.1 (related party transaction) and Rule 4.2.1 (issue of new equity
securities) and on the terms more fully set out in the explanatory notes, is approved.
5. Directors’ fees: That under Listing Rule 2.11.1 (directors’ remuneration) the Board is
authorised to increase the aggregate maximum annual amount of fees that can be paid to
Directors from $200,000 approved in 2020 to $350,000, with such increase taking effect on 1
September 2026.
PROCEDURAL NOTES
Proxies
Any shareholder of Promisia who is entitled to attend and vote at the Meeting may appoint a proxy to
attend and vote on their behalf. A corporation which is a shareholder may appoint a representative to
attend the Meeting on its behalf in the same manner as it could appoint a proxy. A proxy does not need
to be a shareholder of Promisia. A proxy form can be returned by delivery, mail, email, or online (as set
out below).
4
Any Directors are prepared to act as proxy for shareholders. Where any Director is appointed as a
discretionary proxy and is not prohibited from voting, each of the Directors intends to vote in favour of
all the resolutions. Shareholders are encouraged to give express voting directions to any Director that
they appoint as their proxy. As the Chair (Rhonda Sherriff) is unable to vote on Resolution 4 and all
Directors are prohibited from voting on Resolution 5, any discretionary proxies given to the Chair will be
abstained from voting on Resolution 4 and any discretionary proxies given to any Director will be
abstained from voting on Resolution 5. Those voting restrictions are described further below and also
apply to Associated Persons (as defined in the NZX Listing Rules (Listing Rules)).
To appoint a proxy, you should complete and sign the enclosed proxy form and either return it by
delivery, mail or email to the share registrar of Promisia:
By delivery:
Promisia Healthcare Limited
c/- MUFG Pension & Market Services
Level 30, PWC Tower
15 Customs Street West
Auckland 1010
By email: meetings.nz@cm.mpms.mufg.com (please put the words ‘PHL Proxy Form’ in the subject line
for easy identification)
You may also lodge your proxy online at https://nz.investorcentre.mpms.mufg.com/voting/PHL . You
will need to enter your CSN/Holder Number and Authorisation Code (FIN) to securely complete your
proxy appointment. A shareholder will be taken to have signed the proxy form by lodging it in
accordance with the instructions on the website.
The completed proxy form must be received by MUFG Pension & Market Services no later than 48 hours
before the meeting, being 3pm on Tuesday, 25 August 2026. Online proxy appointments must be
completed by this time also. Registered shareholders at that time will be the only persons entitled to
vote at the Meeting and only the shares registered in those shareholders’ names at that time may be
voted at the Meeting.
Shareholder Questions
Shareholders attending the Meeting will be given the opportunity to raise questions.
Shareholders may also submit written questions on the bottom of the proxy form. The main themes will
be aggregated and responded to at the Meeting. Alternatively, written questions can be sent online at
https://nz.investorcentre.mpms.mufg.com/voting/PHL or by email to francisco.rf@promisia.co.nz.
Promisia reserves the right not to address questions that, in the Chair’s opinion, are not reasonable in
the context of an Annual Shareholders’ Meeting, or any written questions that are not received by 3pm
on Tuesday, 25 August 2026.
Ordinary Resolutions
All resolutions are ordinary resolutions. An ordinary resolution is a resolution passed by more than 50%
of the votes of those shareholders entitled to vote and voting on the resolutions in person or by proxy.
By mail:
Promisia Healthcare Limited
c/- MUFG Pension & Market Services
PO Box 91976
Auckland 1142
5
Voting Restrictions
Under Listing Rule 6.3.1, voting restrictions apply to Resolution 4 and to Resolution 5.
Rhonda Sherriff and her Associated Persons (as that term is defined in the Listing Rules) are excluded
from voting on Resolution 4 as Rhonda Sherriff is (through the Sherriff Interest) a vendor of Chatswood
and a party to the transactions described in Resolution 4.
All directors of Promisia and their respective Associated Persons are excluded from voting on Resolution
5 because the directors are the recipients of the directors’ fees for which approval is sought.
“Associated Person” includes persons or legal entities who are able to directly or indirectly, exert a
substantial degree of influence over the activities of another person or legal entity (or vice versa).
Promisia will disregard any votes cast on Resolution 4 or Resolution 5 by any person to whom the above
restriction applies. Any discretionary proxies given to persons disqualified from voting under the
requirements set out above will not be valid.
Annual Meeting Presentation and FY26 Annual Report
The Meeting presentation and voting results will be announced to the NZX Market following the
Meeting and published on the Company’s website at http://www.promisia.co.nz/investor-
centre/#investor-news.
A copy of Promisia’s FY26 Annual Report is available on the Company’s website at
http://www.promisia.co.nz/investor-centre/#reports-&-results.
To receive Promisia reports by email you can update your communication preferences by visiting the
MUFG Investor Centre at https://nz.investorcentre.mpms.mufg.com or email to
operations.nz@cm.mpms.mufg.com (Please use “PHL Report” as the subject line for easy identification).
Definitions
Capitalised terms not defined in this Notice have the same meaning as in the Listing Rules.
NZ RegCo No Objection
This Notice has been reviewed by NZX Regulation Limited (NZ RegCo). NZ RegCo has confirmed it has
no objection to this Notice but takes no responsibility for the contents of this Notice.
6
Explanatory Notes
Resolution 1: Auditors’ Remuneration
The Companies Act 1993 requires the Company to appoint an auditor and provides that the fees and
expenses of an auditor appointed at an annual meeting can be fixed in the manner determined at
that meeting. Section 207S of the Companies Act 1993 provides that the remuneration of the
auditor is to be fixed in such a manner as the Company determines at the meeting. The Board
proposes that, consistent with commercial practice, the auditor’s remuneration should be fixed by
the directors.
The resolution authorises the Board to fix the remuneration of William Buck Audit (NZ) Limited as
the Company’s auditor.
Resolution 2: Re-election of Craig Percy
Board Role: Independent, non-executive Director
Craig has had over 20 years’ experience in the aged care and retirement village sectors, in both New
Zealand and the United Kingdom. This includes holding the role of Chief Operating Officer at LifeCare
Residences in London and the role of General Manager at ElderCare New Zealand Limited, now part
of NZX-listed Oceania Healthcare. Craig was also previously involved in establishing the Greytown
Orchards retirement village in the Wairarapa.
For the purpose of Listing Rule 7.8.3, the Board considers Craig to be an independent director. The
Board considered all relevant factors, including those set out in Table 2.4 of the NZX Corporate
Governance Code (Code Factors), in determining Craig’s independence. Code Factor 1 was
applicable for the Board in this assessment because Craig served as an executive of the Company
between late 2024 and May 2025. Due to this, the Board also specifically considered whether
triggering Code Factor 1 meant that Craig had a Disqualifying Relationship under the Listing Rules
and could not be considered independent.
A Disqualifying Relationship is having any direct or indirect interest, position, association, or
relationship that could reasonably influence or be reasonably be perceived to influence, in a material
way, Craig’s capacity to bring an independent view to decisions, act in the bests of Promisia, or
represent the interests of shareholders generally, having regard to the Code Factors. The Board
formed the view that that Craig does not have a Disqualifying Relationship, and that it was
reasonable for Craig to return to independent director status as of 31 May 2026. In particular, the
Board did not consider that his service as an executive would influence his ability to bring an
independent view or act in the best interests of Promisia or its shareholders given that:
• His executive role was only for six months on a part time basis to support Promisia while the
Board recruited a permanent Chief Operating Officer;
• His role involved providing temporary operational leadership rather than longer term
strategic or financial decision making; and
• All statutory financial reporting covering the period in which he provided assistance has
been completed.
The Board unanimously supports the re-election of Craig.
7
Resolution 3: Re-election of Rhonda Sherriff
Board Role: Independent, non-executive Director, Chair of the Board
Rhonda has worked in the aged care sector for over 30 years in governance, senior leadership,
clinical, quality and operational management roles. Rhonda is currently a Board member of the New
Zealand Aged Care Association. Rhonda commenced her career as a registered nurse and regularly
consults to the industry providing support and advice to a number of industry providers.
For the purpose of Listing Rule 7.8.3, the Board considers Rhonda to be an independent director. The
Board considered all relevant factors, including the Code Factors, in determining Rhonda’s
independence and considers that none of the Code Factors apply to Rhonda. The Board does not
consider that completing the Acquisition, should Resolution 4 be approved, will result in Rhonda
losing her independence as no Code Factors will ostensibly apply to Rhonda, and there is no other
reason that causes Rhonda to have a Disqualifying Relationship.
The Board unanimously supports the re-election of Rhonda.
Resolution 4: Acquisition of Chatswood Retirement Village
Background
Promisia has entered into an agreement (Agreement) with the shareholders of Chatswood
Retirement Limited (CRL) and Chatswood Lifecare Limited (CLL) to purchase 100% of the shares on
issue in each of those companies. Together CRL and CLL own and operate Chatswood Retirement
Village (Chatswood). Under the Agreement the purchase price of Chatswood is $25 million (the
Acquisition). If the Acquisition is completed, Promisia will own and operate Chatswood through
owning all of the shares of CRL and CLL.
About Chatswood
Chatswood is located at 60 Hawford Road, Opawa, Christchurch, within close proximity to Aldwins
House, one of Promisia’s existing aged care facilities.
CRL owns the land and buildings comprising Chatswood and is the retirement village operator. CLL
manages the integrated village and care operations, providing rest home and hospital-level aged
care, together with assisted-living services, across the 29 care beds, 42 care suites and 29 serviced
apartments. Together, CLL and CRL comprise an integrated care facility and retirement village.
The shareholders of CLL and CRL (the Vendors) are Aged Care Trust Limited (the Ennor Interest) and
HC Trustees 2010 Limited, Rhonda Jane Sherriff and Peter John Sherriff (together, the Sherriff
Interest).
The Chatswood site comprises of a purpose built and integrated high needs aged care and
retirement village complex spanning 1.2643 hectares. CRL owns freehold title to the Chatswood
property, and the property is situated 4.5km from the Christchurch CBD. The property is permitted
for use as a retirement village and care facility and benefits from dual street access and close
proximity to local medical and community facilities.
The original rest home at Chatswood dates back to 1990 and is now obsolete following extensions
and redevelopment of the property. The extensions to the original rest home were completed across
five stages beginning in 2013, with the most recent stage completed in 2023. As a result of these
8
works, the accommodation available to Chatswood residents are primarily modern studio care suites
and studio and one- and two-bedroom serviced apartments.
There is further scope to develop the operations at Chatswood by re-developing the original rest
home wing and certain adjoining residential sites. Altogether, there is an estimated 2,600m
2
of
development land available, including land occupied by the original rest home wing and two
adjoining residential properties. While these development opportunities are part of the strategic
rationale behind the Acquisition, Promisia’s initial priority will be operational integration and any
development will be considered in the future as part of the Board’s broader capital allocation
decisions across the entire Promisia portfolio.
Related Party Involvement
The Sherriff Interest is associated with Rhonda Sherriff, the Chair of Promisia. When discussions first
commenced regarding the Acquisition the non-interested directors on the Promisia Board formed a
sub-committee (being Tony Mortenson, Tom Brankin, Jill Hatchwell and Craig Percy) to provide
governance oversight of the Acquisition process and the negotiation of the key commercial terms.
Operational and negotiation work on the Acquisition was otherwise led by Promisia’s executive
leadership team with external legal and valuation support. In the Board’s view, the Acquisition has
been negotiated and agreed on a commercial arm’s length basis.
Rhonda Sherriff did not participate in any Board deliberations, decisions or negotiations relating to
the Acquisition in her capacity as a Promisia director and recused herself from Board meetings at any
time that the Acquisition was discussed.
Rationale for the Acquisition
The Board considers that a Material Transaction with a Related Party is appropriate in this context,
as the Acquisition has clear strategic merit for Promisia. Since acquiring the Golden View and
Ripponburn facilities in Cromwell approximately two years ago, Promisia’s core focus has been on
lifting occupancy at its facilities and realising operational efficiencies across its facilities to create a
strong foundation for further growth by acquisition. A number of potential acquisitions have been
considered over this time and either disregarded (particularly due to location, local market
demographics or differing views on value) or remain under investigation. The non-interested
directors considered Chatswood a compelling opportunity to pursue given its strategic fit with the
existing portfolio, strong reputation for resident care and strong financial performance.
Acquiring Chatswood gives Promisia development optionality in a high demand market for aged
care, leveraging its operational platform to improve financial performance and care outcomes for
residents. Promisia’s strategy is to continue growing its portfolio of facilities and with its current
facilities performing strongly and an effective leadership team in place, the Board considers Promisia
is now well placed to take further growth steps by acquiring an asset that fits strongly within its
operating profile:
- Locality: Located near Aldwins House and Promisia’s national support office, creating a
stronger East Christchurch cluster and enabling group resources to support operational
performance at Chatswood.
9
- Complementary offering: Chatswood’s care suites, serviced apartments and ORA-based
retirement living complement Aldwins House’s care-only offering, allowing Promisia to serve
a broader range of residents within the same community.
- Demographics: The demographics of Christchurch indicate continued growth in demand for
aged care in the medium to long term.
- Development Opportunity: There is an opportunity to further develop the Chatswood
property to increase resident capacity in the future.
- Reputation: Promisia considers that Chatswood has a strong reputation for delivering high
quality care to residents and notes that Chatswood recently received a four-year
certification from the Ministry of Health, the highest certification period available under
New Zealand’s aged care certification framework.
Chatswood is a logical addition to Promisia’s existing portfolio of five residential care facilities and
three retirement villages. Along with regional clusters in Feilding (Ranfurly Manor and Nelson Street)
and Cromwell (Golden View and Ripponburn), Chatswood creates a third cluster in Christchurch and,
in particular, east Christchurch, alongside Aldwins House. Aldwins House is a care facility with
resthome and hospital beds only and accordingly Chatswood, with its retirement village operations,
adds to Promisia’s continuum of care offering in east Christchurch with the added benefit of being
located close to Promisia’s national support office which is also in east Christchurch. Shareholders
are encouraged to review Promisia’s FY26 Annual Report for further information on Promisia’s
strategy, Promisia’s existing portfolio of facilities and their recent performance.
Acquisition Terms
If the Acquisition goes unconditional, completion is agreed to occur on 1 October 2026 (Completion
Date). On the Completion Date Promisia will satisfy the purchase price in full and acquire the shares
in Chatswood and will become the sole owner and operator of Chatswood from that time.
As at the date of this Notice, the Acquisition is conditional on:
(a) Promisia shareholder approval as is being sought under Resolution 4;
(b) Promisia being satisfied that arrangements acceptable to Promisia have been put in place to
secure the ongoing employment of the employees it considers key to the ongoing operation
of the business following Completion;
(c) there being no material adverse change to the assets, land, or business of Chatswood up
until the Completion Date; and
(d) Promisia being satisfied that the vendors have taken all reasonable steps to ensure that a
Code Compliance Certificate will be issued under the Building Act for certain recent works
that were undertaken at Chatswood.
If any conditions are not satisfied the Acquisition may not proceed. The vendors will remain
responsible (and liable) for obtaining the code compliance certificate referred to under condition (f)
noted above following the Completion Date if it is not obtained by that time.
10
Each of the conditions (except for the material adverse change condition) is due to be satisfied by 31
August 2026 (the Condition Date). Accordingly, Promisia expects the Acquisition to otherwise be
unconditional no later than the Condition Date.
The sale and purchase agreement otherwise contains provisions considered customary for a
transaction of this nature such as business warranties, a tax indemnity and operating requirements
through until the Completion Date. Promisia’s due diligence investigations verified that Chatswood
has been very well run and operates at a high level of compliance in a highly regulated sector.
Purchase Price
The Purchase Price for Chatswood is NZ$25,000,000 (plus GST if any), subject to a customary
adjustment (Purchase Price). The Purchase Price will be satisfied as follows:
(a) NZ$24,000,000 payable in cash on the Completion Date. A deposit equal to 5% of the
purchase price will be payable once the sale and purchase agreement becomes
unconditional (other than in respect of the material adverse change condition);
(b) the issue of up to 1,000,000 fully paid ordinary shares in Promisia (the Consideration Shares)
to the Sherriff Interest at an issue price of NZ$0.50 per share (having a value of up to
NZ$500,000) on the terms of a subscription agreement (Subscription Agreement)
summarised below; and
(c) the issue of a convertible note with a principal amount of NZ$500,000 (the Convertible
Note) to the Ennor Interest on the terms of a convertible note agreement (Convertible Note
Agreement) summarised below.
The Subscription Agreement and the Convertible Note Agreement are the only material ancillary
agreements to the sale and purchase agreement. We summarise the key terms of each agreement
below.
Promisia may elect to satisfy all or any part of the Consideration Shares or the Convertible Note
component of the Purchase Price by paying the equivalent amount in cash at Completion, in which
case the number of Consideration Shares or amount of the Convertible Note will be reduced
accordingly.
The Convertible Note will bear interest at 0% per annum and matures 12 months after the
Completion Date. The Convertible Note is convertible into fully paid ordinary shares in Promisia at an
issue price of NZ$0.50 per share at any time during the term (in increments of NZ$50,000) at the
option of the Ennor Interest. To the extent not converted, the principal will be repayable in full at
maturity. The Convertible Note will be unsecured debt of Promisia ranking equally with all other
unsecured creditors.
The Consideration Shares will be issued to the Sherriff Interest at Completion, ranking equally with
all existing Promisia ordinary shares from allotment.
There are no escrow or trading restrictions applicable to the Consideration Shares or any shares
issued on conversion of the Convertible Note.
As part of approving the Acquisition under Resolution 4 shareholders are also being asked to
specifically approve the issue of the Consideration Shares and the Convertible Note for the purposes
of the Listing Rules.
11
Independent Valuation
After indicatively agreeing the Purchase Price for Chatswood (based on its historic financial
performance, previous valuations of Chatswood and the potential value of Chatswood within
Promisia), Promisia commissioned an independent valuation on Chatswood from CBRE Limited
(CBRE) dated 31 July 2026 (the CBRE Valuation). The purpose of the valuation was to validate the
negotiated purchase price and assist the Board in establishing a carrying value for Chatswood from
the Completion Date for Promisia’s financial statements.
The CBRE Valuation valued Chatswood at NZ$26.2 million, being NZ$1.2 million above the Purchase
Price. The value of Chatswood was broken down into three components:
• Operator’s interest: $16.15 million, representing 61.64% of the market value;
• Care Facility: $8.9 million, representing 33.97% of the market value; and
• Development Land: $1.115 million, representing 4.26% of the market value.
The key assumptions behind the CBRE Valuation are:
• ORA terms: future ORA sales adopt Promisia’s standard ORA terms;
• Discount rate and growth: a discount rate of 15% has been applied to projected cash flows.
Unit prices are assumed to grow at 1% in year one, increasing to 3 – 3.5% p.a from year five
onwards;
• Resident turnover: average occupancy period of 4.3 years for serviced apartment residents
and 2.9 years for care suite residents;
• Occupancy: long-term stabilised occupancy of 93.1% across 71 beds;
• Market conditions: the CBRE Valuation reflects market sentiment at 31 July 2026; and
• Other assumptions: included average sales prices, expense proportions, compliance with
the Retirement Villages Act 2003, the site being free from contamination, no significant
immediate capital expenditure required for the modern buildings, and transfer of the
Facility’s health certification on Completion.
The Board considers that the CBRE Valuation validates the Purchase Price and can be a reassurance
to shareholders that, despite the related party nature of the Acquisition, there is no inappropriate
transfer of value occurring. A letter from CBRE is appended to this Notice of Meeting summarising
their valuation of Chatswood for shareholder information and confirming CBRE’s independence. For
the purposes of CBRE’s letter, ‘Market Valuation’ is synonymous to Fair Value under NZ IFRS 13, and
can be explained as the price that would be received to sell Chatswood in an orderly transaction
between market participants as at 31 July 2026.
Issue of Equity Securities
The Non-Interested Directors initiated discussions with the Sherriff Interest and the Ennor Interest to
gauge their interest in a sale of Chatswood to Promisia in 2025 as they were aware that the Sherriff
Interest and Ennor Interest were amenable to (without actively seeking at that time) a sale
opportunity. The Vendors were open to a discussing a potential sale but were not highly motivated
sellers, Chatswood is a very well run and profitable business that the Vendors expressed to Promisia
a number of times that they would be content to continue to own. Discussions in late 2025 were
highly prospective and led only to general discussions around potential terms and the Vendors
providing Promisia with some preliminary due diligence information. Promisia was not positioned to
make a new acquisition when those discussions commenced. Instead, the Board and Management
12
were primarily focused on improving operational efficiencies at Promisia’s existing facilities,
consolidating and reducing funding costs and embedding an operating leadership team under
Promisia’s (then new) Chief Operating Officer, Graeme Dodd. This disciplined focus was a success as
demonstrated by a strong financial result, a significant valuation uplift across Promisia’s facilities and
a significant reduction in Promisia’s borrowing costs in the FY26 financial results.
In late January 2026, Promisia was well positioned. Having undertaken preliminary due diligence,
formal negotiations commenced and the Non-Interested Directors and senior management then
proposed, negotiated and in late April 2026 entered an indicative non-binding term sheet with the
Sherriff Interest and the Ennor Interest to acquire Chatswood.
As part of the Acquisition the Board sought that a modest equity component to the Purchase Price
was included to mitigate the level of borrowings Promisia would assume and to align the interests of
the Sherriff Interest and the Ennor Interest with Promisia’s shareholders. Following discussions over
the course of March and April 2026, Promisia proposed an issue price for the new shares at $0.50c
per share on 21 April 2026 (when Promisia’s shares were trading at $0.445c per share). The Vendors
accepted this offer, and the term sheet was signed, on 24 April 2026. The Board acknowledges that
the share price has since risen but this issue price formed part of the overall commercial
negotiations at that point in time and actually represented a premium to the then share price of the
Company.
Should all Consideration Shares be issued under the Subscription Agreement, and all shares be
issued on conversion of the Convertible Note, Promisia will issue 2 million Shares in aggregate in part
fulfilment of the Purchase Price. This represents 3.78% of all shares on issue at the date of this
Notice. A shareholder who currently holds 5% of the shares on issue in Promisia, will hold 4.82% of
the shares on issue in Promisia if both the Consideration Shares and all shares on conversion of the
Convertible Note are issued.
Financial Performance of Chatswood
The Acquisition is expected to be immediately accretive to Promisia’s underlying earnings and
operating free cash flow.
Based on Chatswood’s current operating performance and the latest financial information available,
on a standalone annualised basis Chatswood is expected to contribute circa:
• $7.0 million of care fee revenue;
• $1.5 million of deferred management fee income; and
• $2.5 million to $3.5 million of operating free cash flow, depending on the timing and level of
occupation right agreement resale activity.
Occupation right agreement resale activity can vary between financial periods and, accordingly, the
operating free cash flow generated by Chatswood will vary from year to year. The summary financial
performance of Chatswood in its last two financial years
1
is:
1
Taken from unaudited consolidated statement of financial performance for CRL and CLL for the periods
stated.
13
YE 31 March 2025 YE 31 March 2026
Total sales
$9,007,832 10,484,697
Operating surplus
$2,288,382 3,814,425
Other income
$37,601 22,158
Net profit
$2,225,914 3,750,489
Promisia has also identified opportunities to improve Chatswood’s financial performance over time
by applying its existing support office capabilities, operating scale and procurement arrangements.
Based on the final CBRE Valuation and the agreed Purchase Price, the Acquisition is expected to
increase Promisia’s net tangible assets per share by approximately 1.1 cents, or 1.0%, based on
Promisia’s net tangible assets per share of $1.09 as at 31 March 2026. This calculation assumes the
Consideration Shares are issued and the Convertible Note remains outstanding as debt.
Assuming all Promisia warrants on issue are exercised and the Convertible Note is converted into
Promisia shares, pro forma fully diluted net tangible assets per share would be approximately $0.89,
based on Promisia’s financial position as at 31 March 2026. This scenario would also result in
approximately $14.2 million of additional cash being introduced into Promisia through the exercise
of the warrants.
In the view of the non-interested directors, the Acquisition provides strong financial benefits for
Promisia and its shareholders, supported by the strategic rationale outlined above.
Purchase Price Funding
Promisia proposes to fund the Acquisitions through a mixture of:
• $20 million of new debt facilities with the Bank of New Zealand (BNZ); and
• Cash on hand.
The key terms of the new BNZ facilities are:
Facilities
Core Facility: A new $15 million customised average rate loan facility,
to sit alongside Promisia’s existing $31.07 million facility.
Bridge Facility: A new $5 million customised average rate loan facility.
Initial term Core Facility: Two year term.
Bridge Facility: Nine month term.
Interest rate In the process of being fixed through interest swaps. It is expected that
the weighted average interest rate across all facilities will range
between 5.6% and 5.9%.
Amortisation Both facilities are interest only for the duration of their Term.
14
Conditions precedent - Statutory supervisor approval of financing and security
arrangements.
- Approval of a registered valuation. This condition has been
satisfied by the CBRE Valuation.
Bank covenants Loan to Value Ratio (LVR): The aggregate borrowing limits for Promisia
with BNZ must not exceed 55% of the market value of Promisia’s
property assets (determined by annual valuations).
Financial Cover: Adjusted EBITDA is to be maintained at a minimum of
2.00x and from 31 December 2026, a minimum of 2.25x.
Security First mortgages over all properties owned by Promisia (subject to the
priority at law of the statutory supervisor interest).
Interlocking guarantee from all members of the Promisia group.
Promisia has received and executed a committed offer from BNZ for the above facilities, and will
draw them down at Completion.
Promisia’s internal forecasting is that following drawdown of the above facilities, Promisia will
comply with the BNZ covenants. Promisia anticipates that its LVR based on drawn bank facilities
immediately following the Completion Date will be approximately 42%.
The new facilities described above are in addition to Promisia’s existing debt facility, which we
summarise below:
Facility Core Facility: A $31.07 million customised average rate loan facility.
Maturity Date 13 December 2027
Covenants As set out for the new BNZ facilities above.
Security First mortgages over all properties owned by Promisia (subject to the
priority at law of the statutory supervisor interest).
Interlocking guarantee from all members of the Promisia group.
Promisia also owes monies to Rivercrest Cromwell Limited for the purchase of Golden View Village in
Cromwell. Promisia currently leases this village and is prepaying the purchase price ahead of final
settlement in August 2028. No interest or other financing costs are payable in respect of this
amount. From August 2024, Promisia was liable to pay:
• $8.64 million in 48 equal monthly instalments of $180,000; and
• A final payment of $4.71 million due in August 2028 (when Promisia will acquire
freehold title to Golden View Village).
15
All monthly instalments have been paid to Rivercrest Cromwell Limited when due and, given the
high level of equity that Promisia will hold in Golden View Village at the time of the final payment,
the Board has a reasonable expectation of drawing debt finance to fund the final payment.
As at 30 June 2026 Promisia held cash liquidity of approximately $4.7 million. Given its high
occupancy rates and positive operating cash flows, the Board considers that Promisia will have more
than sufficient cash on hand at the Completion Date to fund its cash contribution to the Purchase
Price.
Promisia’s currently has approximately 28.3 million $0.50 warrants on issue that expire in March
2027. Given their exercise price is at a discount to the prevailing market price of Promisia shares
($0.76 as at 13 August 2026) it is anticipated that a reasonable proportion of the warrants will be
exercised and provide Promisia with new capital by the warrant expiry date (24 March 2027). The
Board was mindful in pursuing the Acquisition to minimise dilution to shareholders given the
likelihood of new shares being issued and warrant exercise monies being received early next year.
Accordingly, it is anticipated that the bridge facility will be repaid with those warrant proceeds.
Based on Promisia’s current forecasts, the Bridge Facility can also be repaid from operating free cash
flow generated by the Group without reliance on warrant exercise proceeds. Warrant proceeds
would provide additional repayment capacity and accelerate the reduction in bank debt. Given
Promisia’s forecast cash generation and anticipated LVR headroom, the Board considers the risk of
being unable to repay the Bridge Facility at maturity to be low.
Shareholder Approval
Shareholder approval is required under Listing Rule 5.1.1(b) by way of an ordinary resolution. Listing
Rule 5.1.1(b) provides that, except with the prior approval by an ordinary resolution, Promisia may
not enter into any transaction or related series of transactions to acquire, sell, exchange, or
otherwise dispose of assets of Promisia in respect of which the gross value is in excess of 50% of the
Average Market Capitalisation of Promisia. The Purchase Price exceeds 50% of the Average Market
Capitalisation of Promisia as at 5 August 2026 (being the date of entry into the Acquisition and when
the announcement of Acquisition was released to shareholders on the NZX).
While the Listing Rules prescribe that this test is assessed against market capitalisation, shareholders
should note that the Purchase Price represents only 12.5% of Promisia’s total assets and Promisia’s
market capitalisation reflects that Promisia’s share price is trading at a 30.0% discount to Promisia’s
current NTA per share of $1.092.
Shareholder approval is also required under Listing Rule 5.2.1 by way of an ordinary resolution.
Listing Rule 5.2.1 provides that the Company must not enter into a Material Transaction if a Related
Party is, or is likely to become, a direct party to the Material Transaction, or a beneficiary of a
guarantee or other transaction which is a Material Transaction, unless that Material Transaction is
approved by an ordinary resolution of shareholders. Rhonda Sherriff is a Related Party of the
Company by virtue of being a director of the Company. The Acquisition constitutes a Material
Transaction because it involves the acquisition of assets with a gross value above 10% of Promisia's
Average Market Capitalisation. As Rhonda Sherriff is a direct party to the Material Transaction
(through the Sherriff Interest being a vendor), shareholder approval is required under Listing Rule
5.2.1.
16
Shareholder approval is also required under Listing Rule 4.2 as the issue of the Consideration Shares
is proposed to be made solely to the Sheriff Interest, an Associated Person of Rhonda Sherriff, a
director of Promisia. Accordingly, under Listing Rule 4.5.1(e)(ii), Promisia cannot issue the
Consideration Shares via its placement capacity and must seek shareholder approval. Shareholder
approval is also sought under Listing Rule 4.2 to approve the issue of the Convertible Notes.
For completeness, the Acquisition does not constitute a “major transaction” for the purposes of
section 129 of the Companies Act 1993.
Should shareholders not approve this Resolution, Promisia will not be able to proceed with the
Acquisition and will have to consider different investment opportunities. While there is no break fee
associated with the Acquisition, Promisia will have incurred significant sunk costs in having pursued
the Acquisition through legal fees, registry fees, regulatory fees and finance establishment charges.
It will also lose the opportunity to acquire what the Board consider to be a high quality asset that is a
strong strategic fit with Promisia on terms it considers likely to be value accretive to Promisia and
shareholders.
Waiver granted
Listing Rule 7.8.8(b) ordinarily requires an Appraisal Report to be prepared where a meeting of
shareholders will consider a resolution required by Listing Rule 5.2.1. NZ RegCo has granted Promisia
a waiver from this requirement.
Listing Rule 7.8.5(b) requires certain information to be provided to shareholders in connection with a
resolution to approve an issue of equity securities to a Related Party. Promisia has obtained a waiver
from NZ RegCo from Listing Rule 7.8.5(b).
A copy of NZ RegCo's waiver decision, including its reasons, was announced to market on 13 August
2026.
Non-Interested Director Recommendation
The Non-Interested Directors unanimously recommend that shareholders vote in favour of
Resolution 4 and certifies that in its opinion:
- The Share Issue is in the best interests of, and fair and reasonable to, Promisia and all non-
associated shareholders;
- The Acquisition is in the best interests of, and fair and reasonable to, Promisia and all non-
associated shareholders;
- The terms of the Acquisition (including the Purchase Price) were negotiated on an arm’s
length commercial basis;
- Promisia was not influenced to enter into the Acquisition by Rhonda Sherriff;
- The waivers are in the best interests of, and fair and reasonable to, Promisia and all non-
associated shareholders; and
- No inappropriate transfer of value is accruing to the Sherriff Interest as a consequence of the
Acquisition being a related party transaction.
The non-interested Directors reiterate that Rhonda Sherriff has not taken part in any of the Board’s
discussions or decisions regarding the Acquisition and has engaged in the Acquisition solely in her
capacity as a vendor, not as a director of the Company.
17
Resolution 5: Increase to the Directors Fee Pool
Resolution 5 seeks shareholder approval to increase the aggregate maximum annual amount of fees
that can be paid to Directors from $200,000 (Previous Fee Pool) to $350,000 (Proposed Fee Pool). If
the Proposed Fee Pool is approved, it will apply from 1 September 2026.
Directors and their Associated Persons are prohibited from voting on this Resolution 5.
Previous Fee Pool
The Previous Fee Pool was approved as a monetary sum per annum payable to all Directors of
Promisia taken together. At the time, Promisia had four directors. Under the Listing Rules, if the total
number of Directors subsequently increases, the Directors may, without a further shareholders
resolution, increase the director fee pool by such amount as is necessary to enable Promisia to pay
the average (non-Chair) director remuneration to the new director.
After the Previous Fee Pool was approved by shareholders, the number of directors on the Promisia
Board increased to five directors. Accordingly, the Previous Fee Pool automatically increased to
$245,000.
The Previous Fee Pool was allocated and paid amongst the current Board as follows:
Role Fee Pool Allocation
Chair of Board (x1) $75,000
Non-executive director (x3) $45,000
Executive Director (x1) Nil
Total $210,000
No additional fees are currently paid to Committee Chair’s or in respect of Committee memberships.
Executive Director
Tom Brankin became an executive director after the Previous Fee Pool was approved. Consequently,
he received $120,000 per annum in base remuneration for his executive role and ceased receiving
directors fees from the Director fee pool. As advised to the market earlier this year, Tom is ceasing
his executive services to Promisia from the time of the shareholders meeting and will then continue
in office as a non-executive director.
Accordingly, Resolution 5 is partly being put to shareholders to increase the capacity in the pool so
that there is capacity to pay Tom Brankin from the Director fee pool.
Market Review
In addition to ensuring the above capacity, approval of the Proposed Fee Pool is sought to ensure
that Promisia is paying its directors a market rate of directors’ fees that is sufficient to attract and
retain high-calibre directors. Factors supporting an increase to the Previous Fee Pool include:
- Inflation in the six years since the Previous Fee Pool was approved.
18
- Considerable growth in the scale and operations of Promisia, including:
o The acquisition of the Golden View and Ripponburn facilities in Cromwell.
o The acquisition of Aldwins House.
o Completion of the Ranfurly Manor villa expansion.
o Establishment of the Promisia support office and senior executive team.
- The strong improvement in financial performance by Promisia.
- Continued development and growth initiatives (including the Acquisition and development
opportunities remaining in the current facility portfolio) that place significant time demands
on the directors.
- The increased workload of Board sub-committees and the need to have capacity in the fee
pool to fairly remunerate directors for their workload in that regard. When the Previous Fee
Pool was approved, given the scale of Promisia at that time, much of the governance work
usually undertaken by committees was undertaken by the Board as a whole.
- In addition, special sub-committees may be set up from time to time to provide governance
oversight of specific initiatives in Promisia (such as redevelopments or acquisitions) and it
would be appropriate for the directors fee pool to have some capacity to pay additional fees
to directors where they are asked to invest additional time on key matters for Promisia that
drive value for shareholders.
The level of the Proposed Fee Pool was then determined with the Board having regard to:
- fees paid by other listed companies of a similar market capitalisation to Promisia.
- fees paid by other listed companies that operate in healthcare.
- the similarity in risk profile of those companies to Promisia.
- the expected further expansion of Promisia’s asset and operating base and the
corresponding expected increase in demands on the directors.
- The Institute of Directors 2025/26 Directors Fees Report which suggests that a general New
Zealand market median fee for a non-executive director is $53,700.
If approved the Board proposes to allocate the Proposed Fee Pool as follows:
Role Proposed annual fee
Chair of the Board $87,000
Non-executive directors (four directors at $54,000 per annum) $216,000
Risk, Audit and Assurance Committee Chair - Additional Fee $6,000
Contingency (special fees for sub-committee work or similar) $41,000
Total $350,000
Satisfying Directors Fees through Equity Securities
When the Previous Fee Pool was approved, shareholders also approved Promisia satisfying directors
fees through an issue of equity securities in accordance with Listing Rule 4.7. This flexibility will
remain if the Proposed Fee Pool is approved.
19
Listing Rule 4.7 only allows Promisia to issue equity securities to directors if:
• The equity securities are of a class already on issue;
• The issue of equity securities is made after the end of the period or half period to which that
remuneration is payable; and
• The issue price of the equity securities is not less than the ‘Average Market Price’ before the
issue occurs.
20
Appendix: Valuation letter from CBRE on Chatswood
N:\NZ-AKL-Vals_Health\Promisia\Chatswood\2026 06\Correspondence\2026 07 Chatswood Confirmation
Ltr.docx
CBRE Limited
Level 37, ANZ Centre
23-29 Albert Street
PO Box 2723
Auckland, New Zealand
T 64 9 355 3333
F 64 9 359 5430
www.cbre.co.nz
VVALUATION & ADVISORY SERVICES
27 July 2026
Promisia Healthcare Limited
919 Colombo Street
Christchurch 8013
Attention: Mr Francisco Rodriguez Ferrere
Confirmation of Value
Chatswood Retirement Village, 60 Hawford Road, Opawa, Christchurch
In accordance with instructions, we inspected the above complex on 21 July 2026 and have
completed a Market Valuation for potential acquisition purposes with an effective date of 31 July
2026.
We confirm we have assessed a value of $26,200,000 (Twenty Six Million, Two Hundred Thousand
Dollars) on the basis of a going concern and zero rated for GST, with land valued plus GST, if any.
We confirm that the valuers involved in the preparation of the valuation do not have any conflicts of
interest, nor any relationship with Promisia Healthcare Limited that would impair the objectivity or
independence of the valuer(s), or CBRE, when preparing the valuation.
We trust this meets your immediate requirements however we remain available to discuss further if
required.
Yours sincerely
CBRE Limited
Michael Gunn,
B.Com (VPM), SNZIV, MRICS
Registered Valuer
Senior Director – Retirement Housing & Healthcare
---
Go online to https://nz.investorcentre.mpms.mufg.com/voting/PHL to appoint your proxy
LODGE YOUR PROXY
Proxy Form/Admission Card for Promisia Healthcare Limited 2026 Annual Shareholders’ Meeting
Notice is hereby given that the Annual Shareholders’ Meeting of Promisia Healthcare Limited (“the Company”) will be held at Duncan Cotterill, 148 Victoria
Street, Christchurch, Ōtautahi at 3pm (New Zealand time) on Thursday, 27 August 2026. If you will attend the Meeting, please bring this form to assist with
your registration.
Shareholders unable to attend in person may observe the meeting online at this link: Microsoft Teams Meeting
If you will not attend the meeting but wish to be represented by proxy, please complete and return this form (in accordance with the lodgment instructions
above) to Promisia Healthcare Limited’s share registry, MUFG Pension & Market Services, by no later than 3pm on Tuesday, 25 August 2026. You can
also appoint your proxy and vote on the resolutions on the reverse of this form online by going to https://nz.investorcentre.mpms.mufg.com/voting/PHL or
by scanning the QR code above with your smartphone.
Thursday, 27 August 2026 at 3:00pm (New Zealand time)
CSN/Holder Number: <CSN/Holder Number>
*Barcode*
Duncan Cotterill, 148 Victoria Street, Christchurch, Ōtautahi
Appointment of proxy
If you are entitled to vote at the meeting, you may appoint a proxy to attend
the meeting and vote on your behalf, unless specifically excluded. The
proxy need not also be a shareholder. If you wish, you may appoint any
director of the Company as your proxy or as alternative to your named
proxy. Each Director intends to vote all discretionary proxies in favour of the
relevant resolution however shareholders are encouraged to provide
express voting instructions on this form given the Chair is disqualified from
voting on Resolution 4 and all directors are disqualified from voting on
Resolution 5. Any discretionary proxies given to a director disqualified from
voting on a particular resolution will be disregarded.
Voting of your holding
Direct your proxy how to vote by making the appropriate election, either
online or on this Proxy Form, in respect of each resolution. If you return this
form without directing the proxy how to vote on any particular matter, the
proxy may vote as he/she thinks fit or abstain from voting. If you make more
than one election in respect of a resolution your vote will be invalid on that
resolution. If this Proxy Form is returned duly signed by a Shareholder with
voting instructions included, but without specifying a person that is
appointed as proxy, the Chair of the Meeting is deemed to be the proxy for
the purpose of that form, but only to vote to the extent of the voting
instructions provided.
Attending the meeting
If you plan to attend the meeting in person, please bring this Admission
Card/Proxy Form intact as the barcode will assist in your registration.
A corporation may appoint a person as its representative to attend and vote
at the Meeting in the same manner as that in which it could appoint a proxy.
That person need not also be a shareholder.
Signing instructions for this form
Individual
Where the holding is in one name, the shareholder must sign the Proxy
Form.
Joint Holding
Where the holding is in more than one name, at least one joint shareholder
should sign this form (on behalf of all joint shareholders). If different joint
shareholders purport to appoint different proxies, the vote of the proxy
appointed by the first named joint shareholder shall apply.
Power of Attorney
If this Proxy Form has been signed under a power of attorney, a copy of the
power of attorney under which it was signed (if not previously provided to
the Registrar), and a signed certificate of non-revocation of the power of
attorney must accompany this Proxy Form.
Corporate Shareholder
In the case of a corporate shareholder, a duly authorised officer or director
must sign this Proxy Form. Persons who sign on behalf of a corporate
shareholder must be acting with that corporate shareholder’s express or
implied authority.
Online
https://nz.investorcentre.mpms.mufg.com/voting/PHL
Scan & email
meetings.nz@cm.mpms.mufg.com
Scan this QR code with
your smartphone and vote
online
Mail
Use the enclosed reply paid
envelope or address to:
MUFG Pension & Market Services
PO Box 91976
Auckland 1142
General Enquiries
Email
enquiries.nz@cm.mpms.mufg.com
Phone
+64 9 375 5998
Space and position for name and address
Step 1 Appoint a Proxy / Corporate Representative
I/We being a shareholder/s of Promisia Healthcare Limited hereby appoint:
Name
or failing him/her:
Address
Name Address
As my/our proxy to vote for me/us on my/our behalf at the Annual Meeting of the Company to be held at 3pm on Thursday, 27 August 2026, and at any
adjournment of that Meeting.
Step 2 Items of Business – Voting Instructions
Instruct a proxy to vote by placing a tick in the relevant box. If you have appointed a proxy and want him/her to decide how to vote on the resolution, tick the
box “Proxy’s discretion”. Please note for each resolution you must tick one box.
Step 3 Shareholder Questions
Shareholders attending the Annual Shareholders’ Meeting will have the opportunity to ask questions during the meeting. If you cannot attend the Annual
Shareholders’ Meeting but would like to ask a question, you can submit a question online by going to https://nz.investorcentre.mpms.mufg.com/voting/PHL
and completing the online validation process or complete the question section below and return to MUFG Pension & Market Services in the envelope enclosed.
Questions will need to be submitted by 3pm on Tuesday, 25 August 2026. The Board will endeavour to address and answer questions at the Annual
Shareholders’ Meeting.
Question:
Step 4 Signature of Shareholder(s) This section must be completed
Shareholder 1
or duly authorised officer or attorney
Shareholder 2
or duly authorised officer or attorney
Shareholder 3
or duly authorised officer or attorney
Contact Name
Contact Daytime Telephone
Date
Electronic Investor Communications
If you received the Notice of Meeting and Proxy Form by mail and wish to receive your future investor communications by email please provide your email
address below:
To consider and, if thought fit, pass the following ordinary resolutions:
FOR AGAINST ABSTAIN
PROXY
DISCRETION
1. 1. To authorise the directors to fix the auditor’s remuneration for the ensuing year.
2. 2. That Craig Percy, who retires by rotation and is eligible for re-election, be re-elected as a
director of Promisia.
3. 3. That Rhonda Sherriff, who retires by rotation and is eligible for re-election, be re-elected as
a director of Promisia.
4. 4. That Promisia undertaking the Acquisition under Listing Rule 5.1.1 (major transaction),
5.2.1 (related party transaction) and Rule 4.2.1 (issue of new equity securities) and on the
terms more fully set out in the explanatory notes, is approved.
5. 5. That under Listing Rule 2.11.1 (directors’ remuneration) the Board is authorised to increase
the aggregate maximum annual amount of fees that can be paid to Directors from $200,000
approved in 2020 to $350,000, with such increase taking effect on 1 September 2026.
CSN/Holder Number: 123456789
*Barcode*
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.